Efficacy of a short course of parent-initiated oral prednisolone for viral wheeze in children aged 1-5 years: Randomised controlled trial

Lancet

Volumn 362, Issue 9394, 2003, Pages 1433-1438

  Oommen, Abraham ^a   Lambert, Paul C ^a   Grigg, Jonathan ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; EOSINOPHIL PROTEIN X; PLACEBO; PREDNISOLONE;

AGE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG EFFICACY; DRUG SCREENING; EOSINOPHIL; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGHT; OUTCOMES RESEARCH; PARENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SCORING SYSTEM; STRATIFICATION; SYMPTOM; VIRAL WHEEZE; WHEEZING;

EID: 0242266584     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14685-5     Document Type: Article

References (28)

1. Kurukulaaratchy R.J., Fenn M.H., Waterhouse L.M., Matthews S.M., Holgate S.T., Arshad S.H. Characterization of wheezing phenotypes in the first 10 years of life. Clin Exp Allergy. 33:2003;573-578.
2. O'Donnell R.A., Frew A.J. Is there more than one inflammatory phenotype in asthma? Thorax. 57:2002;566-568.
3. La Grutta S., Gagliardo R., Mirabella F., et al. Clinical and biological heterogeneity in children with moderate asthma. Am J Respir Crit Care Med. 167:2003;1490-1495.
4. Stein R.T., Holberg C.J., Morgan W.J., et al. Peak flow variability, methacholine responsiveness and atopy as markers for detecting different wheezing phenotypes in childhood. Thorax. 52:1997;946-952.
5. British guideline on the management of asthma. Thorax 2003; 58 (suppl 1): 1-94.
6. Louis R., Lau L.C., Bron A.O., Roldaan A.C., Radermecker M., Djukanovic R. The relationship between airways inflammation and asthma severity. Am J Respir Crit Care Med. 161:2000;9-16.
7. Venge P., Bystrom J., Carlson M., et al. Eosinophil cationic protein (ECP): molecular and biological properties and the use of ECP as a marker of eosinophil activation in disease. Clin Exp Allergy. 29:1999;1172-1186.
8. Mertsola J., Ziegler T., Ruuskanen O., Vanto T., Koivikko A., Halonen P. Recurrent wheezy bronchitis and viral respiratory infections. Arch Dis Child. 66:1991;124-129.
9. Kuehni C.E., Davis A., Brooke A.M., Silverman M. Are all wheezing disorders in very young (preschool) children increasing in prevalence? Lancet. 357:2001;1821-1825.
10. Silverman M., Wang M., Hunter G., Taub N. Episodic viral wheeze in preschool children: effect of topical nasal corticosteroid prophylaxis. Thorax. 58:2003;431-434.
11. Sherrill D.L., Stein R., Halonen M., Holberg C.J., Wright A., Martinez F.D. Total serum IgE and its association with asthma symptoms and allergic sensitization among children. J Allergy Clin Immunol. 104:1999;28-36.
12. Martinez F.D., Wright A.L., Taussig L.M., Holberg C.J., Halonen M., Morgan W.J. Asthma and wheezing in the first six years of life. The Group Health Medical Associates. N Engl J Med. 332:1995;133-138.
13. Villa J.R., Garcia G., Rueda S., Nogales A. Serum eosinophilic cationic protein may predict clinical course of wheezing in young children. Arch Dis Child. 78:1998;448-452.
14. Weinberger M. Treatment strategies for viral respiratory infection-induced asthma. J Pediatr. 142:2003;34-38.
15. Rowe B.H., Spooner C., Ducharme F.M., Bretzlaff J.A., Bota G.W. Early emergency department treatment of acute asthma with systemic corticosteroids (Cochrane Review). The Cochrane Library, Issue 2. 2003;Update Software, Oxford.
16. Weinberger M. Consensus statement from a conference on treatment of viral respiratory infection-induced asthma in young children. J Pediatr. 142:2003;45-46.
17. Webb M.S., Henry R.L., Milner A.D. Oral corticosteroids for wheezing attacks under 18 months. Arch Dis Child. 61:1986;15-19.
18. Fox G.F., Marsh M.J., Milner A.D. Treatment of recurrent acute wheezing episodes in infancy with oral salbutamol and prednisolone. Eur J Pediatr. 155:1996;512-516.
19. Brunette M.G., Lands L., Thibodeau L.P. Childhood asthma: prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infection. Pediatrics. 81:1988;624-629.
20. Wilson N.M., Silverman M. Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Arch Dis Child. 65:1990;407-410.
21. Koller D.Y., Wojnarowski C., Herkner K.R., et al. High levels of eosinophil cationic protein in wheezing infants predict the development of asthma. J Allergy Clin Immunol. 99:1997;752-756.
22. Remes S., Korppi M., Remes K., Savolainen K., Mononen I., Pekkanen J. Serum eosinophil cationic protein (ECP) and eosinophil protein X (EPX) in childhood asthma: the influence of atopy. Pediatr Pulmonol. 25:1998;167-174.
23. Taussig L.M., Wright A.L., Holberg C.J., Halonen M., Morgan W.J., Martinez F.D. Tucson Children's Respiratory Study: 1980 to present. J Allergy Clin Immunol. 111:2003;661-675.
24. Shields M.D., Brown V., Stevenson E.C., et al. Serum eosinophilic cationic protein and blood eosinophil counts for the prediction of the presence of airways inflammation in children with wheezing. Clin Exp Allergy. 29:1999;1382-1389.
25. Grant C.C., Duggan A.K., DeAngelis C. Independent parental administration of prednisone in acute asthma: a double-blind, placebo-controlled, crossover study. Pediatrics. 96:1995;224-229.
26. Kayani S., Shannon D.C. Adverse behavioral effects of treatment for acute exacerbation of asthma in children: a comparison of two doses of oral steroids. Chest. 122:2002;624-628.
27. Shapiro G. Steroids and asthma. Pediatrics. 96:1995;347-348.
28. Smith M., Iqbal S., Elliot T.M., Everard M., Rowe B.H. Corticosteroids for hospitalised children with acute asthma (Cochrane Review). The Cochrane Library, Issue 2. 2003;Update Software, Oxford.